Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Genmab
M.D. Anderson Cancer Center
Seagen Inc.
Shasqi, Inc.
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
Precision Biologics, Inc
Revolution Medicines, Inc.
Elevation Oncology
Cedars-Sinai Medical Center
Advaxis, Inc.
Universitair Ziekenhuis Brussel
Genmab
Kineta Inc.
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Imperial College London
Instituto do Cancer do Estado de São Paulo
Bay Area Gynecology Oncology
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Duke University
Ohio State University Comprehensive Cancer Center
New Mexico Cancer Research Alliance
Astellas Pharma Inc